The canonical targets for steroid hormones are cytosolic nuclear receptors that function to change cellular processes, over hours or days, through modification of gene transcription, which is considered a genomic effect [1]. However, controversy in the literature exists from studies that have demonstrated rapid, non-genomic (transcription independent) effects of steroid hormones [2]. The purpose of this editorial is to review the evidence supporting a role for non-genomic effects of the stress hormone corticosterone in the body's response to stress.Anything that causes a deviation from homeostasis can be considered a stressor. However, if the stressor is due to an actual or perceived threat to one's well-being, the body responds by activating the sympathomedullary axis (the classical 'fight' or 'flight' response), the autonomic response, the hypothalamo-pituitary-adrenal (HPA) axis and the neuroendocrine response. The HPA axis is initiated by release of corticotropin-releasing factor (CRF) from the paraventricular nucleus of the hypothalamus (PVN) into the hypophyseal portal circulation to bind in the anterior pituitary. Adrenocorticotropic hormone (ACTH) is then released from the pituitary into the systemic circulation to bind in the adrenal cortex to cause the synthesis and release of the glucocorticoid cortisol (corticosterone in rodents). Corticosterone then acts through feedback inhibitory mechanisms within the pituitary, PVN and limbic sites such as the hippocampus to terminate the HPA axis [3]. The inhibitory mechanisms are produced as the net result of binding to two distinct but related receptors: the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR) [4,5].Both GR and MR are members of the 3-ketosteroid nuclear receptor superfamily, which also includes progesterone and androgen receptors [6]. These receptors act as transcriptions factors, meaning that they reside in the cytoplasm in a complex of chaperone proteins and translocate to the nucleus after ligand binding. Corticosterone is an endogenous ligand for both receptors. MR, the high affinity receptor, is predominantly occupied under basal corticosterone secretion, in contrast to the lower affinity GR receptor which is only bound in response to stress-induced increases in plasma corticosterone [5,7]. Complexes of ligand-bound homo or heterodimers of GR and MR within the nucleus can directly bind to DNA and either initiate transcription if bound with co-activators or inhibit gene expression if bound with co-repressors [8,9]. While GR is ubiquitously expressed, MR expression is localized to discrete neuronal populations including the hippocampus and the hypothalamus [6]. Importantly, while these slow, genomic effects of GR and MR serve to modify long-term neuronal physiology, there is increasing evidence from electrophysiological studies for rapid, non-genomic effects of these receptors through putative membrane receptors in specific brain nuclei [10].The effects of corticosterone on the electrophysiology of pyramidal neurons in the ...